Literature DB >> 19845678

Haem oxygenase-1 induction protects against tumour necrosis factor alpha impairment of endothelial-dependent relaxation in rat isolated pulmonary artery.

Hany M El-Bassossy1, Nabila N El-Maraghy, Hassan M El-Fayoumi, Malcolm L Watson.   

Abstract

BACKGROUND AND
PURPOSE: Disturbances in pulmonary vascular reactivity are important components of inflammatory lung disease. Haem oxygenase-1 (HO-1) is an important homeostatic enzyme upregulated in inflammation. Here we have investigated the potentially protective effect of HO-1 against cytokine-induced impairment in pulmonary artery relaxation. EXPERIMENTAL APPROACH: Haem oxygenase-1 protein levels were assessed by immunofluorescence. HO activity was assessed by conversion of haemin to bilirubin. Rings of rat isolated pulmonary artery in organ baths were used to measure relaxant responses to the endothelium-dependent agent ACh and the endothelium-independent agent sodium nitroprusside (SNP). Production of nitric oxide (NO) and reactive oxygen species (ROS) was assessed by confocal fluorescence microscopy and fluorescent probes. KEY
RESULTS: Haem oxygenase-1 protein expression was strongly induced in pulmonary artery after 24-h incubation with either haemin (5 microM) or curcumin (2 microM), accompanied by a significant increase in HO activity. Incubation with tumour necrosis factor alpha (TNFalpha, 1 ng.mL(-1), 2 h) significantly decreased relaxation of arterial rings to ACh, without affecting responses to SNP. Induction of HO-1 by curcumin or haemin protected against TNFalpha-induced hyporesponsiveness to ACh. The competitive HO inhibitor, tin protoporphyrin (20 microM), abolished the protective effect of haemin. HO-1 induction prevented a TNFalpha-induced increase in NO generation without affecting the TNFalpha-induced increase in ROS generation. HO-1 induction prevented the TNFalpha-induced decrease in ACh-stimulated NO generation. CONCLUSIONS AND IMPLICATIONS: Induction of HO-1 protected against TNFalpha impairment of endothelium-dependent relaxation in pulmonary artery, by a mechanism involving a reduction in inducible NO synthase-derived NO production.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19845678      PMCID: PMC2795219          DOI: 10.1111/j.1476-5381.2009.00419.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  46 in total

1.  Optimization of the paired enzyme assay for heme oxygenase activity.

Authors:  Stephen J McNally; James A Ross; O James Garden; Stephen J Wigmore
Journal:  Anal Biochem       Date:  2004-09-15       Impact factor: 3.365

2.  Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats.

Authors:  D G Hemmings; Y Xu; S T Davidge
Journal:  Br J Pharmacol       Date:  2004-08-23       Impact factor: 8.739

3.  Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers.

Authors:  G Scapagnini; R Foresti; V Calabrese; A M Giuffrida Stella; C J Green; R Motterlini
Journal:  Mol Pharmacol       Date:  2002-03       Impact factor: 4.436

4.  Effect of tumour necrosis factor-alpha and interleukin 1beta on endothelium-dependent relaxation in rat mesenteric resistance arteries in vitro.

Authors:  R Wimalasundera; S Fexby; L Regan; S A McG Thom; A D Hughes
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

5.  Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteries.

Authors:  Raquel Hernanz; Ana M Briones; María J Alonso; Elisabet Vila; Mercedes Salaices
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-03-04       Impact factor: 4.733

Review 6.  Nitric oxide in health and disease of the respiratory system.

Authors:  Fabio L M Ricciardolo; Peter J Sterk; Benjamin Gaston; Gert Folkerts
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

7.  Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension.

Authors:  Ulf Landmesser; Sergey Dikalov; S Russ Price; Louise McCann; Tohru Fukai; Steven M Holland; William E Mitch; David G Harrison
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

8.  Mechanisms involved in the early increase of serotonin contraction evoked by endotoxin in rat middle cerebral arteries.

Authors:  Raquel Hernanz; Maria J Alonso; Ana M Briones; Elisabet Vila; Ulf Simonsen; Mercedes Salaices
Journal:  Br J Pharmacol       Date:  2003-10       Impact factor: 8.739

9.  Heme oxygenase-mediated endothelial dysfunction in DOCA-salt, but not in spontaneously hypertensive, rat arterioles.

Authors:  Fruzsina K Johnson; William Durante; Kelly J Peyton; Robert A Johnson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-12-23       Impact factor: 4.733

Review 10.  Carbon monoxide and hypertension.

Authors:  Joseph F Ndisang; Hortense E Nsoh Tabien; Rui Wang
Journal:  J Hypertens       Date:  2004-06       Impact factor: 4.844

View more
  9 in total

1.  Tissue heme oxygenase-1 exerts anti-inflammatory effects on LPS-induced pulmonary inflammation.

Authors:  F M Konrad; U Knausberg; R Höne; K-C Ngamsri; J Reutershan
Journal:  Mucosal Immunol       Date:  2015-05-06       Impact factor: 7.313

2.  Pentoxifylline alleviates vascular impairment in insulin resistance via TNF-α inhibition.

Authors:  Hany M El-Bassossy; Mohamed A El-Moselhy; Mona F Mahmoud
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-07-29       Impact factor: 3.000

Review 3.  Role of curcumin in ameliorating hypertension and associated conditions: a mechanistic insight.

Authors:  Priyanka Joshi; Sushil Joshi; Deepak Kumar Semwal; Kanika Verma; Jaya Dwivedi; Swapnil Sharma
Journal:  Mol Cell Biochem       Date:  2022-05-15       Impact factor: 3.842

4.  Heme oxygenase-1 induction protects against hypertension associated with diabetes: effect on exaggerated vascular contractility.

Authors:  N Hassan; H M El-Bassossy; M N M Zakaria
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-12-20       Impact factor: 3.000

5.  Arginase inhibition alleviates hypertension in the metabolic syndrome.

Authors:  Hany M El-Bassossy; Rania El-Fawal; Ahmed Fahmy; Malcolm L Watson
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

6.  Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress.

Authors:  Jessica R Santos-Parker; Talia R Strahler; Candace J Bassett; Nina Z Bispham; Michel B Chonchol; Douglas R Seals
Journal:  Aging (Albany NY)       Date:  2017-01-03       Impact factor: 5.682

Review 7.  Cannabinoids for Treating Cardiovascular Disorders: Putting Together a Complex Puzzle.

Authors:  Basma Ghazi Eid
Journal:  J Microsc Ultrastruct       Date:  2018 Oct-Dec

Review 8.  Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage.

Authors:  Fuzhou Wang; Xirong Guo; Xiaofeng Shen; Richard M Kream; Kirk J Mantione; George B Stefano
Journal:  Med Sci Monit Basic Res       Date:  2014-08-01

9.  Interference with AGEs formation and AGEs-induced vascular injury mediates curcumin vascular protection in metabolic syndrome.

Authors:  Osama A A Ahmed; Hany M El-Bassossy; Ahmad S Azhar; Mayada M Tarkhan; Mahmoud M El-Mas
Journal:  Sci Rep       Date:  2020-01-15       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.